If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

this represents a significant step into the gene therapy space for Vertex. 3. VX-548 for Chronic Pain: Investors are eagerly awaiting Phase 2 data for VX-548 in low back pain (LSR), expected by ...

The 52-week low price of Vertex Securities Ltd () is Rs 3 ABOUT ... Jai Corp sees smallcap index exclusion 'Mazaa nahin aa raha...': HAL faces criticism as IAF chief raises red flags at Aero ...

The open-source server, currently in public beta, is also compatible with LangChain — a modular framework for Python and ...